Newsfile Corp
13 Aug 2026, 11:45 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
ARS Pharmaceuticals failed to secure expanded insurance coverage for neffy through CVS Caremark by the July 1, 2026 deadline, missing the summer and back-to-school seasons. — Loss of key insurance coverage during peak demand seasons directly impairs revenue generation and commercialization success for a primary product.
-0.80CVS Caremark has reserved its decision on expanded insurance coverage for neffy until January 2027. — This creates a long-term uncertainty and a significant gap in market access that persists for several months.
-0.60A federal securities fraud class action lawsuit alleges that ARS officers made false or misleading statements regarding the timeline for CVS Caremark coverage. — Legal action and allegations of corporate misconduct introduce regulatory risk and potential financial liabilities.
-0.40Continue reading
6 related stories
Top 1 mover · tap to explore
Grabar Law Office is investigating whether ARS Pharmaceuticals' officers and directors breached their fiduciary duties to shareholders. — Shareholder governance actions can lead to corporate instability and management turnover, though they are secondary to the product's commercial failure.
-0.20Which stocks this story touches
The company is facing a securities fraud class action lawsuit and a significant stock price decline due to failed insurance coverage deadlines.
The company is mentioned as the subject of a shareholder claims investigation by a law office.
The company is mentioned as the subject of a shareholder claims investigation by a law office.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
1h ago
